Table 4.
Multivariate analysis
| Variable | RFS | PFS | OS | |||
|---|---|---|---|---|---|---|
| HR (95% CI) | p | HR (95% CI) | p | HR (95% CI) | p | |
| Age | ||||||
| ≤ 72 | 1.00 | 1.00 | 1.00 | |||
| > 72 | 3.23 (1.73–6.04) | <0.001 | 3.08 (1.26–7.54) | 0.014 | 7.38 (3.63–15.01) | <0.001 |
| Sex | - | - | - | - | ||
| Female | 1.00 | |||||
| Male | 0.78 (0.35–1.77) | 0.557 | ||||
| Prior UC | - | - | - | - | ||
| Yes | 1.00 | |||||
| No | 1.62 (0.82-3.21) | 0.166 | ||||
| Concomitant pT1 | - | - | - | - | ||
| No | 1.00 | |||||
| Yes | 1.49 (0.86–2.60) | 0.160 | ||||
| CIS focality | - | - | - | - | ||
| Unifocal | 1.00 | |||||
| Multifocal | 1.12 0.62–2.01) | 0.704 | ||||
| Smoking status | - | - | - | - | ||
| Never | 1.00 | |||||
| Former | 0.54 (0.12–2.45) | 0.420 | ||||
| Current | 3.91 (1.59–9.62) | 0.003 | ||||
| BCG therapy | - | - | - | - | ||
| No | 1.00 | |||||
| Yes | 0.62 (0.35–1.09) | 0.099 | ||||
| Recurrence at first FU | - | - | - | - | ||
| No | 1.00 | |||||
| Yes | 1.50 (0.76–2.97) | 0.240 | ||||
p values < 0.05 were considered significant and are shown in italics
CI, confidence interval; FU, follow-up, HR, hazard ratio, OS, overall survival, PFS, progression-free survival, RFS, recurrence-free survival; UC, urothelial carcinoma